ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
37.50
0.30
(0.81%)
Cerrado 05 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
37.50
Postura de Compra
37.30
Postura de Venta
37.50
Volume Operado de la Acción
206
37.30 Rango del Día 37.50
35.00 Rango de 52 semanas 40.00
Capitalización de Mercado [m]
Precio Anterior
37.20
Precio de Apertura
37.30
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
565
Acciones en circulación
3,166,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
13.70
Beneficio por acción (BPA)
2.74
turnover
23.31M
Beneficio neto
8.67M

Acerca de Warehouses Estates Belgium SA

Sector
Real Estate Investment Trust
Industria
Real Estate Investment Trust
Sitio web
Sede
Charleroi, Hainaut, Bel
Fundado
-
Warehouses Estates Belgium SA is listed in the Real Estate Investment Trust sector of the Euronext with ticker WEB. The last closing price for Warehouses Estates Belgium was 37.20 €. Over the last year, Warehouses Estates Belgium shares have traded in a share price range of 35.00 € to 40.00 €.

Warehouses Estates Belgium currently has 3,166,000 shares in issue. The market capitalisation of Warehouses Estates Belgium is 117.78 € million. Warehouses Estates Belgium has a price to earnings ratio (PE ratio) of 13.70.

WEB Últimas noticias

Compulsory Acqn of Shares

RNS Number:4650O Durlacher Corporation PLC 08 August 2003 Not for release, publication or distribution in or into the United States, Canada, Australia or Japan Embargoed until...

Directorate Change

RNS Number:9621N Web-Angel PLC 25 July 2003 25th July 2003 web-angel plc Re-Directorate Following the announcement on 22 July 2003 that the Offer by Nabarro Wells & Co. Limited on...

EMM Disclosure

RNS Number:8564N KBC Peel Hunt (EMM) 23 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

Offer Update

RNS Number:8394N Durlacher Corporation PLC 22 July 2003 22 July 2003 This announcement is not for release, publication or distribution in or into the USA, Canada, Australia or Japan...

EMM Disclosure

RNS Number:5527N KBC Peel Hunt (EMM) 15 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

Further re Offer

RNS Number:5437N Durlacher Corporation PLC 15 July 2003 Durlacher Corporation Plc For immediate release 15 July 2003 This announcement is not for release, publication or distribution in...

EMM Disclosure

RNS Number:3878N KBC Peel Hunt (EMM) 10 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

EMM Disclosure

RNS Number:3352N KBC Peel Hunt (EMM) 09 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

EMM Disclosure

RNS Number:1101N KBC Peel Hunt (EMM) 03 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

EMM Disclosure

RNS Number:0517N KBC Peel Hunt (EMM) 02 July 2003 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.51.351351351353737.536.932137.10989867DE
40.41.078167115937.137.836.553637.12489572DE
12-2.1-5.3030303030339.639.63656537.70925943DE
260.51.3513513513537403661338.17089121DE
521.13.0219780219836.4403560337.93907159DE
156-4-9.6385542168741.543.531.269137.37542998DE
260-22.5-37.5606331.279641.02230338DE

WEB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Warehouses Estates Belgium?
El precio actual de las acciones de Warehouses Estates Belgium es 37.50 €
¿Cuántas acciones de Warehouses Estates Belgium están en circulación?
Warehouses Estates Belgium tiene 3,166,000 acciones en circulación
¿Cuál es la capitalización de mercado de Warehouses Estates Belgium?
La capitalización de mercado de Warehouses Estates Belgium es EUR 117.78M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Warehouses Estates Belgium?
Warehouses Estates Belgium ha negociado en un rango de 35.00 € a 40.00 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Warehouses Estates Belgium?
El ratio precio/beneficio de Warehouses Estates Belgium es 13.7
¿Cuál es el ratio de efectivo a ventas de Warehouses Estates Belgium?
El ratio de efectivo a ventas de Warehouses Estates Belgium es 5.09
¿Cuál es la moneda de reporte de Warehouses Estates Belgium?
Warehouses Estates Belgium presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Warehouses Estates Belgium?
El último ingresos anual de Warehouses Estates Belgium es EUR 23.31M
¿Cuál es el último beneficio anual de Warehouses Estates Belgium?
El último beneficio anual de Warehouses Estates Belgium es EUR 8.67M
¿Cuál es la dirección registrada de Warehouses Estates Belgium?
La dirección registrada de Warehouses Estates Belgium es 29 AVENUE JEAN MERMOZ, CHARLEROI, HAINAUT, B-6041
¿Cuál es la dirección del sitio web de Warehouses Estates Belgium?
La dirección del sitio web de Warehouses Estates Belgium es www.w-e-b.be
¿En qué sector industrial opera Warehouses Estates Belgium?
Warehouses Estates Belgium opera en el sector REAL ESTATE INVESTMENT TRUST

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M
BDEZ BDEZ 1 minuto hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 minuto hace
Not good, thanks for sharing.
sand sand 8 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 9 minutos hace
Moving hard soon 
EFSH
mining101 mining101 10 minutos hace
Superb
MEGL
benz280c benz280c 17 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 24 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 25 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 28 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 33 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 34 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 39 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 41 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 42 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 44 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 47 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 50 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 50 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 51 minutos hace
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 53 minutos hace
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 54 minutos hace
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 1 hora hace
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hora hace
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII

Su Consulta Reciente

Delayed Upgrade Clock